These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10926934)

  • 1. c-Crk, a substrate of the insulin-like growth factor-1 receptor tyrosine kinase, functions as an early signal mediator in the adipocyte differentiation process.
    Jin S; Zhai B; Qiu Z; Wu J; Lane MD; Liao K
    J Biol Chem; 2000 Nov; 275(44):34344-52. PubMed ID: 10926934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blockade of preadipocyte differentiation by protein-tyrosine phosphatase HA2 is reversed by vanadate.
    Liao K; Lane MD
    J Biol Chem; 1995 May; 270(20):12123-32. PubMed ID: 7744861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes.
    Ribon V; Saltiel AR
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):839-45. PubMed ID: 9210408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
    Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation.
    Xu J; Liao K
    J Biol Chem; 2004 Aug; 279(34):35914-22. PubMed ID: 15192111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes.
    Ribon V; Printen JA; Hoffman NG; Kay BK; Saltiel AR
    Mol Cell Biol; 1998 Feb; 18(2):872-9. PubMed ID: 9447983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoliquiritigenin impairs insulin signaling and adipocyte differentiation through the inhibition of protein-tyrosine phosphatase 1B oxidation in 3T3-L1 preadipocytes.
    Park SJ; Choe YG; Kim JH; Chang KT; Lee HS; Lee DS
    Food Chem Toxicol; 2016 Jul; 93():5-12. PubMed ID: 27117918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk.
    Beitner-Johnson D; LeRoith D
    J Biol Chem; 1995 Mar; 270(10):5187-90. PubMed ID: 7534289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the major SHPTP2-binding protein that is tyrosine-phosphorylated in response to insulin.
    Yamauchi K; Ribon V; Saltiel AR; Pessin JE
    J Biol Chem; 1995 Jul; 270(30):17716-22. PubMed ID: 7629070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth arrest induces primary-cilium formation and sensitizes IGF-1-receptor signaling during differentiation induction of 3T3-L1 preadipocytes.
    Zhu D; Shi S; Wang H; Liao K
    J Cell Sci; 2009 Aug; 122(Pt 15):2760-8. PubMed ID: 19596798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
    Boney CM; Gruppuso PA; Faris RA; Frackelton AR
    Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein-tyrosine kinase fer associates with signaling complexes containing insulin receptor substrate-1 and phosphatidylinositol 3-kinase.
    Iwanishi M; Czech MP; Cherniack AD
    J Biol Chem; 2000 Dec; 275(50):38995-9000. PubMed ID: 11006284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes.
    Standaert ML; Sajan MP; Miura A; Bandyopadhyay G; Farese RV
    Biochemistry; 2004 Dec; 43(49):15494-502. PubMed ID: 15581361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells.
    Ogawa S; Toyoshima H; Kozutsumi H; Hagiwara K; Sakai R; Tanaka T; Hirano N; Mano H; Yazaki Y; Hirai H
    Oncogene; 1994 Jun; 9(6):1669-78. PubMed ID: 8183562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
    Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
    Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
    Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
    Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.